Results 41 to 50 of about 1,264,620 (412)
Inhibition of oncogenic transcription factor REL by the natural product derivative calafianin monomer 101 induces proliferation arrest and apoptosis in human B-lymphoma cell lines [PDF]
, 2015 Increased activity of transcription factor NF-κB has been implicated in many B-cell lymphomas. We investigated effects of synthetic compound calafianin monomer (CM101) on biochemical and biological properties of NF-κB.
Chennamadhavuni, Spandan +4 more
core +2 more sources
Blood, 2017 Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. Although 5-year survival rates in the first-line setting range from 60% to 70%, up to 50% of patients become refractory to or relapse after treatment.
M. Crump +16 more
semanticscholar +1 more source
Evidential segmentation of 3D PET/CT images [PDF]
arXiv, 2021 PET and CT are two modalities widely used in medical image analysis. Accurately detecting and segmenting lymphomas from these two imaging modalities are critical tasks for cancer staging and radiotherapy planning. However, this task is still challenging due to the complexity of PET/CT images, and the computation cost to process 3D data.
arxiv
Agarose gel serum protein electrophoresis in cats with and without lymphoma and preliminary results of tandem mass fingerprinting analysis [PDF]
, 2011 <b>Background</b>: Serum electrophoretic profiles in cats are poorly characterized with respect to the protein components of the globulin fractions, and interpretation of the electrophoretograms has routinely been done in ignorance of the ...
Baker +36 more
core +1 more source
Medicine, 2019 when it became clear that it is caused by a change in the DNA (deoxyribonucleic acid) of lymphocytes in the lymphatic system.
D. Wrench, Paul Fields
semanticscholar +1 more source
Cancer Cell, 2002 363 Epidemiology Lymphomas comprise the fifth most common cancer type in the United States, with approximately 55,000 cases of nonHodgkin’s lymphoma (NHL) and 7,400 cases of Hodgkin’s lymphoma (HL) each year. An unexplained finding is the 80% rise in NHL between 1973 and 1997 (http://www.seer.cancer.gov).
Louis M. Staudt, Wyndham H. Wilson
openaire +3 more sources
NF-κB signaling and its relevance to the treatment of mantle cell lymphoma
Journal of Hematology & Oncology, 2018 Mantle cell lymphoma is an aggressive subtype of non-Hodgkin B cell lymphoma that is characterized by a poor prognosis determined by Ki67 and Mantle Cell International Prognostic Index scores, but it is becoming increasingly treatable.
Swathi Balaji +5 more
doaj +1 more source
Journal of Hematology & Oncology, 2021 Mantle cell lymphoma (MCL) is a rare, aggressive and incurable subtype of non-Hodgkin’s B-cell lymphoma. The principal barrier is frequent clinical relapse to multiple lines of therapies, including new FDA-approved biologics and cell therapy ...
Vivian Changying Jiang +8 more
doaj +1 more source
Deep PET/CT fusion with Dempster-Shafer theory for lymphoma segmentation [PDF]
arXiv, 2021 Lymphoma detection and segmentation from whole-body Positron Emission Tomography/Computed Tomography (PET/CT) volumes are crucial for surgical indication and radiotherapy. Designing automatic segmentation methods capable of effectively exploiting the information from PET and CT as well as resolving their uncertainty remain a challenge.
arxiv
An evaluation of machine learning techniques to predict the outcome of children treated for Hodgkin-Lymphoma on the AHOD0031 trial: A report from the Children's Oncology Group [PDF]
Applied Artificial Intelligence 2020, 2020 In this manuscript we analyze a data set containing information on children with Hodgkin Lymphoma (HL) enrolled on a clinical trial. Treatments received and survival status were collected together with other covariates such as demographics and clinical measurements.
arxiv +1 more source